# LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Canonical URL: https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026-269755ae
Ticker: LMAT
Company: LeMaitre Vascular
Source: LeMaitre Vascular
Published: 2026-07-14 21:43 EST
## Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026...

## Article Body
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here . All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com .

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
## Recent Company News
- 2026-07-14 21:43 EST — [LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026-269755ae) — Source: LeMaitre Vascular
- 2026-05-20 20:25 EST — [LeMaitre to Participate at Upcoming Investor Conferences in June](https://biopharmsignal.com/news/LMAT/lemaitre-to-participate-at-upcoming-investor-conferences-in-june-a4d71e69) — Source: LeMaitre Vascular
- 2026-05-07 21:15 EST — [LeMaitre to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/LMAT/lemaitre-to-present-at-the-bank-of-america-healthcare-conference-3f9a75f1) — Source: LeMaitre Vascular
- 2026-05-05 20:05 EST — [LeMaitre Q1 2026 Financial Results](https://biopharmsignal.com/news/LMAT/lemaitre-q1-2026-financial-results-1a3119ae) — Source: LeMaitre Vascular
- 2026-04-14 20:54 EST — [LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026-b7240d53) — Source: LeMaitre Vascular
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)